NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

PFE

Pfizer Inc

May 22 • 04:00PM ET

23.04

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO SPY IVV VTV XLV VYM VHT COWZ DVY

Scroll to Statements

Index	S&P 500	P/E	16.70	EPS (ttm)	1.38	Insider Own	0.18%	Shs Outstand	5.68B	Perf Week	1.95%
Market Cap	130.99B	Forward P/E	7.47	EPS next Y	3.08	Insider Trans	0.17%	Shs Float	5.67B	Perf Month	2.90%
Income	7.87B	PEG	-	EPS next Q	0.57	Inst Own	67.07%	Short Float	2.03%	Perf Quarter	-12.40%
Sales	62.46B	P/S	2.10	EPS this Y	-3.57%	Inst Trans	-1.56%	Short Ratio	2.13	Perf Half Y	-7.32%
Book/sh	15.89	P/B	1.45	EPS next Y	2.81%	ROA	3.67%	Short Interest	115.16M	Perf Year	-19.24%
Cash/sh	3.05	P/C	7.56	EPS next 5Y	-0.30%	ROE	8.62%	52W Range	20.92 - 31.54	Perf YTD	-13.15%
Dividend Est.	1.71 (7.40%)	P/FCF	11.68	EPS past 5Y	-13.25%	ROI	5.32%	52W High	-26.95%	Beta	0.53
Dividend TTM	1.70 (7.38%)	Quick Ratio	0.96	Sales past 5Y	17.19%	Gross Margin	66.93%	52W Low	10.16%	ATR (14)	0.63
Dividend Ex-Date	May 09, 2025	Current Ratio	1.26	EPS Y/Y TTM	2770.58%	Oper. Margin	27.53%	RSI (14)	48.93	Volatility	2.01% 2.70%
Employees	81000	Debt/Eq	0.69	Sales Y/Y TTM	13.38%	Profit Margin	12.59%	Recom	2.38	Target Price	28.26
Option/Short	Yes / Yes	LT Debt/Eq	0.64	EPS Q/Q	-5.13%	Payout	119.94%	Rel Volume	0.71	Prev Close	23.04
Sales Surprise	-1.47%	EPS Surprise	38.22%	Sales Q/Q	-7.82%	Earnings	Apr 29 BMO	Avg Volume	54.15M	Price	23.04
SMA20	-0.50%	SMA50	-2.65%	SMA200	-12.83%	Trades		Volume	38,553,402	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60

Show Previous Ratings

Today 10:48AM	MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot (Zacks)
07:42AM	5 Low Price-to-Sales Stocks That Can Deliver Big Returns in 2025 (Zacks)
06:52AM	FDA advisers pan Pfizers PARP drug; Sarepta to resume Duchenne study (BioPharma Dive)
May-21-25 04:32PM	Citi Maintains a Hold Rating on Pfizer (PFE) Amidst Pricing Policy Headwinds (Insider Monkey)
02:22PM	Bernstein Reaffirms Pfizer Rating After $6B Cancer Treatment Deal (Insider Monkey)
11:55AM	Loading…
11:55AM	Home Depot backs outlook as U.S. sales ticked up: Morning Buzz (TipRanks)
11:10AM	FDA to mandate trials for COVID boosters for healthy kids and adults (TipRanks)
09:08AM	The Zacks Analyst Blog Highlights Pfizer, Coca-Cola and The Walt Disney (Zacks)
08:37AM	MRNA, PFE Stocks Jump Despite FDA's Stricter Standards for COVID-19 Shots (Zacks)
07:00AM	Giant US companies are rushing to Europe to borrow money (Bloomberg)
06:23AM	2 High-Yield Dividend Stocks to Buy Right Now (Motley Fool)
May-20-25 05:01PM	Stocks to Watch Recap: Home Depot, Tesla, Uber, UnitedHealth (The Wall Street Journal)
04:13PM	Trump's Drug Price War Could Slash Big Pharma Profits (GuruFocus.com)
04:10PM	BMO Capital Maintains Buy Rating on Pfizer (PFE) Stock (Insider Monkey)
03:55PM	COVID vaccine guidelines, D-Wave, Viking Cruises: Trending Tickers (Yahoo Finance Video)
02:34PM	Loading…
02:34PM	Pfizer Pacing for 4th Day of Gains (CNBC TV)
01:45PM	Moderna Stock Jumps on New FDA COVID-19 Booster Guidelines (Investopedia)
01:12PM	Bitcoin gains, FDA's vaccine guidance, UnitedHealth recovers (Yahoo Finance Video)
12:22PM	The FDA Is Limiting Covid Shots. But Moderna, Vaccine Stocks Jumped. (Investor's Business Daily)
10:46AM	Pfizer Is Jumping Into a Hot Cancer-Drug Race. It May Have Overpaid. (Barrons.com)
10:27AM	Stocks to Watch Tuesday: Home Depot, Tesla, CATL, Uber (The Wall Street Journal)
10:22AM	MRK, Daiichi Begin Pivotal Esophageal Cancer Study With ADC Drug (Zacks)
09:34AM	Stocks to Watch Tuesday: CATL, Home Depot, UnitedHealth (The Wall Street Journal)
09:34AM	Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China (Investopedia)
09:33AM	Pfizer strikes deal with China's 3SBio to license cancer drug (CNBC TV)
09:00AM	Buy 3 Wide Moat Stocks With Double-Digit Near-Term Upside Potential (Zacks)
08:46AM	Pfizer Buys Rights to PD-1 & VEGF Inhibitor From China Biotech (Zacks)
06:28AM	Pfizer Signs Experimental Drug Licensing Agreement With 3SBio (Zacks)
06:00AM	Pfizer buys into PD-1/VEGF competition with 3SBio deal (BioPharma Dive)
04:37AM	Pfizer signs global licensing deal with 3SBio for bispecific antibody (Pharmaceutical Technology)
03:50AM	Loading…
03:50AM	These 3 Dividend Stocks Yield More Than 6% and Their Payouts Look Safe (Motley Fool)
May-19-25 11:58PM	Pfizer Inc. (PFE) Inks $6 Billion Cancer Drug Licensing Agreement with China's 3SBio (Insider Monkey)
08:35PM	Pfizer in deal with China's 3SBio to license cancer drug candidate, take equity stake (Reuters)
08:00PM	Pfizer Enters into Exclusive Licensing Agreement with 3SBio (Business Wire)
09:42AM	NVAX Stock Surges on Securing FDA Approval for COVID-19 Vaccine (Zacks)
08:29AM	PFE vs. MRK: Which Oncology Drug Giant is a Better Buy Now? (Zacks)
May-18-25 12:05PM	Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut. (Motley Fool)
May-16-25 11:31AM	Lawmakers investigating allegations on timing of Pfizer COVID vaccine, WSJ says (TipRanks)
09:00AM	Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
04:49AM	Here's How Many Shares of Pfizer You Should Own to Make $10,000 in Annual Dividend Income (Motley Fool)
May-15-25 04:43PM	House Pushes Pfizer on Vaccine Timing (GuruFocus.com)
11:20AM	New Allegations About Timing of Pfizer Covid Vaccine Passed to House Panel (The Wall Street Journal)
08:36AM	5 Low Price-to-Book Value Stocks to Buy in May (Zacks)
08:27AM	FDA delays approval decision for Biohaven rare disease drug (BioPharma Dive)
May-14-25 06:05PM	3 Magnificent S&P 500 Dividend Stocks Down 62%, 63%, and 64% to Buy and Hold Forever (Motley Fool)
02:34PM	Analyst Report: Pfizer Inc. (Morningstar Research)
10:15AM	Jim Cramer on Pfizer (PFE) - "Caught in a Vortex, but I'm Sticking with Seagen and Dr. Bourla" (Insider Monkey)
07:46AM	Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer (Zacks)
04:32AM	Court rules in favor of The New York Times over texts between the EU chief and a pharma boss (Associated Press Finance)
03:40AM	EU court annuls rejection of bid for EU's von der Leyen vaccine messages with Pfizer (Reuters)
03:40AM	Court rejects European Commission's refusal to share COVID messages with NY Times (Reuters)
03:40AM	Court annuls European Commission's refusal to disclose COVID texts (Reuters)
May-13-25 05:07PM	Why Pfizer Inc. (PFE) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom (Insider Monkey)
11:40AM	PFE vs. LLY: Which Stock Is the Better Value Option? (Zacks)
11:18AM	Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trumps Executive Order. (Barrons.com)
10:37AM	4 Value Picks to Ride the Market Rebound After US-China Trade Thaw (Zacks)
09:40AM	Should Value Investors Buy Pfizer (PFE) Stock? (Zacks)
09:22AM	The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen (Zacks)
09:00AM	US-China Talks Spark Optimism; Betting Markets See Recession Odds Drop (Zacks)
07:36AM	Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared (Zacks)
May-12-25 08:59PM	Lightning Round: Devon Energy has been a nightmare, says Jim Cramer (CNBC TV)
07:20PM	Trump's drug price order is part request, part threat: Analyst (Yahoo Finance Video)
04:17PM	These Stocks Moved the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More (Barrons.com)
03:50PM	How Trump could go about executing order to slash drug prices (Yahoo Finance Video)
02:58PM	Trump Executive Order Could Reshape How Americans Pay for Drugs. Why It Isnt Bad for Pharma Stocks. (Barrons.com)
02:35PM	Global Pharma Stocks Rebound as Investors See Hurdles in Trump Drug Plan (Investopedia)
02:30PM	These Stocks Are Moving the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More (Barrons.com)
12:34PM	Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order (Yahoo Finance)
10:44AM	Trump expected to sign order to slash US drug prices (Yahoo Finance Video)
09:37AM	Pharma Stocks Hit by Trump's Vow to Cut US Prescription Drug Costs (Zacks)
09:25AM	Zacks.com featured highlights PCB, G-III Apparel, Gibraltar, Pfizer and Pampa Energia (Zacks)
09:09AM	US-China trade truce, April CPI, drug prices: 3 Things (Yahoo Finance Video)
08:50AM	Zacks Market Edge Highlights: WHR, PFE, CVX, CC and DOW (Zacks)
07:55AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:49AM	Pfizer, Eli Lilly, Merck and Other Pharma Stocks Fall as Trump Targets Lower Drug Prices (Barrons.com)
07:38AM	Trumps Vow to Cut US Drug Prices Drags Pharma Stocks Lower (Bloomberg)
07:33AM	Trumps Plan to Cut Drug Prices Hits Pfizer, Other Pharma Stocks (The Wall Street Journal)
04:51AM	Wondering if Pfizer's 7.6% Dividend Yield Is Sustainable? Here's What You Need to Know. (Motley Fool)
04:28AM	Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices (Bloomberg)
May-10-25 05:39AM	3 Magnificent S&P 500 Dividend Stocks Down 30% to Buy and Hold Forever (Motley Fool)
04:17AM	Is Pfizer Inc. (PFE) the Best High-Yield Dividend Stock for 2025 and Beyond? (Insider Monkey)
May-09-25 12:44PM	Are Your Mega-High Stock Dividends Safe? (Zacks)
09:55AM	Pfizer (PFE) Just Overtook the 20-Day Moving Average (Zacks)
08:23AM	Was Jim Cramer Right About Pfizer (PFE)? (Insider Monkey)
08:12AM	5 Low Price-to-Sales Stocks That Deserve a Place in Your Portfolio (Zacks)
May-08-25 10:01PM	If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now? (Benzinga)
11:50AM	A Look at Pharma ETFs After Strong Q1 Earnings (Zacks)
09:55AM	Can Pfizer (PFE) Climb 25.14% to Reach the Level Wall Street Analysts Expect? (Zacks)
05:45AM	Want $3,100 in Annual Dividends? Invest $18,000 in Each of These 3 Stocks (Motley Fool)
04:00AM	Alnylam keeps pushing the rare disease paradigm as RNAi promises even wider indications (Pharma Voice)
12:30AM	Valneva SE: Still Undervalued Travel Vaccine Bet With Robust 2025 Guidance (Seeking Alpha)
May-07-25 04:51PM	Trump planning on Executive Order to further cut Medicare drug prices - report (Seeking Alpha)
02:54PM	FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight (Benzinga)
01:50PM	Jim Cramer on Pfizer (PFE): "Trying Big Targets, but New Wins Still Elusive" (Insider Monkey)
11:35AM	2024 Total Dividend Income And Portfolio Update (Seeking Alpha)
10:32AM	Pfizer, J&J, Genentech drugs subject of FDA advisory panel meeting this month (Seeking Alpha)
05:30AM	Trump Is Threatening Big Pharma With Tariffs. Tax Changes Might Work Better. (The Wall Street Journal)
May-06-25 06:15PM	Why BioNTech Stock Got Trounced on Tuesday (Motley Fool)
01:25PM	Trump Sets Pharma Tariffs Deadline. The Fallout for Lilly, Pfizer, Other Drugmakers. (Barrons.com)
09:54AM	Moderna Sharpens Pipeline Focus as COVID-19 Vaccine Demand Ebbs in Q1 (Zacks)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM
Gottlieb Scott	Director	Oct 30 '24	Buy	28.24	1,000	28,240	10,000	Oct 31 04:06 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 13 '24	Sale	28.66	5,154	147,714	8,582	Aug 14 03:47 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience